TABLE 2

Patient and Encounter Characteristics at the Time of Each Infusion (n) by Study Period

Period 1Period 2Period 3
n = 84n = 34n = 35
Ordering provider specialty, n (%)
 Nephrology10 (12)11 (32%)13 (37%)
 Rheumatology74 (88)23 (68%)22 (63%)
Infusion setting, n (%)
 Outpatient29 (35)12 (35%)10 (29%)
 Inpatient55 (65)22 (65%)25 (71%)
Insurance Type, n (%)
 Public49 (58)14 (41%)22 (63%)
 Commercial35 (42)20 (59%)13 (37%)
Length of stay (d), median (IQR)a0.9 (0.8–1.5)0.9 (0.8–4.9)1.1 (0.8–32.6)
  • Period 1: pathway launch to REMS protocol launch (7/1/2011–5/22/2013); period 2: REMS/provider education (5/23/2013–2/24/2014); period 3: MOC and EMR order set update (2/25/2014–6/30/2015). IQR, interquartile range.

  • a Length of stay for inpatient encounters only.